Esperion Therapeutics
ESPR
#6587
Rank
A$1.17 B
Marketcap
A$4.55
Share price
0.00%
Change (1 day)
98.09%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): A$0.11 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are A$0.41 Billion. In 2025 the company made an earning of A$91.3 Million, an increase over its 2024 earnings that were of A$10.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.11 B30.12%
2025 A$91.3 M749.49%
2024 A$10.74 M-104.99%
2023 -A$0.22 Billion-15.03%
2022 -A$0.26 Billion-20.61%
2021 -A$0.32 Billion84.28%
2020 -A$0.18 Billion35.75%
2019 -A$0.13 Billion-55.71%
2018 -A$0.29 Billion19.57%
2017 -A$0.25 Billion125.39%
2016 -A$0.11 Billion51.43%
2015 -A$70.55 Million36.45%
2014 -A$51.71 Million43.55%
2013 -A$36.02 Million145.26%
2012 -A$14.69 Million
2002 -A$41.87 Million-7.81%
2001 -A$45.42 Million15.03%
2000 -A$39.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.16 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.38 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-A$0.77 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$37.37 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.27 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA